![FirstTake on Pharma - Pharma News and Analysis Podcast artwork](https://is2-ssl.mzstatic.com/image/thumb/Podcasts114/v4/a2/db/cc/a2dbccbb-dacd-4b87-c44c-c2ebcc45ed2f/mza_6559862663847131014.png/100x100bb.jpg)
The FirstTake Podcast – A landmark approval in lupus
FirstTake on Pharma - Pharma News and Analysis Podcast
English - August 05, 2021 19:00 - 16 minutes - 12.5 MB - ★★★★★ - 2 ratingsScience pharma pharmaceutical intelligence firstword firsttake cardiovascular dermatology diabetes immunology infectious diseases Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: The FirstTake Podcast – A tale of two COVID-19 vaccines
This week FirstWord Pharma PLUS editors Michael Flanagan and Simon King discuss US approval of the first new lupus therapy in a decade, Eli Lilly’s optimistic body language about bringing a new Alzheimer’s disease treatment to market next year and Sanofi’s acquisition of messenger RNA specialist Translate Bio.